AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2012
Aug 10, 2012
35323_dirs_2012-08-10_5753efeb-5fa6-4415-b574-2cce109ca751.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2012-08-09
Reporting Person: STEER RANDOLPH C (Consultant)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-09 | Stock Option (Right to Buy) | $0.16 | A | 65000 | Acquired | 2022-08-09 | Common Stock (65000) | Direct |
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16